Assignee
D&D PHARMATECH INC
KR·3 granted patents·6 pending applications·2 citations·filing 2015–2025
Top patents by PatentIndex Score
9 records- 0176US10406230B2Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredientD&D PHARMATECH INC·Filed 2017·Granted Sep 10, 2019·2 cites·20 claims
- 0259US2025127723A1Pharmaceutical composition comprising large physiologically active substance and excipientD&D PHARMATECH INC·Filed 2022·Application pending·0 cites
- 0357US2025270275A1Pharmaceutical composition comprising polypeptideD&D PHARMATECH INC·Filed 2025·Application pending·0 cites
- 0454US12338270B2Pharmaceutical composition comprising polypeptideD&D PHARMATECH INC·Filed 2019·Granted Jun 24, 2025·0 cites·17 claims
- 0553US2025296960A1Peptide compositions and methods of use thereofD&D PHARMATECH INC·Filed 2023·Application pending·0 cites
- 0649US2024000803A1Oral formulation of biologically active material conjugate having biotin moiety, fatty acid moiety, or combination thereof coupled theretoD&D PHARMATECH INC·Filed 2021·Application pending·0 cites
- 0745US2023048956A1Biotin moiety-conjugated polypeptide and pharmaceutical composition for oral administration comprising the sameD&D PHARMATECH INC·Filed 2020·Application pending·0 cites
- 0843US2023000834A1Physiologically active substance bound to biotin moiety, and composition for oral administration including sameD&D PHARMATECH INC·Filed 2020·Application pending·0 cites
- 0927US11299528B2Long acting TRAIL receptor agonists for treatment of autoimmune diseasesD&D PHARMATECH INC·Filed 2015·Granted Apr 12, 2022·0 cites·14 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →